T78240 |
(R)-Elexacaftor
|
2229860-99-3
|
98%
|
|
(R)-Elexacaftor, an enantiomer of Elexacaftor, functions as a modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). It exhibits an EC50 of...
|
T79578 |
CFTR corrector 12
|
958941-60-1
|
98%
|
|
CFTR Corrector 12 (Compound 17C), a bithiazole derivative, functions as a CFTR corrector by remedying certain folding-defective mutants of the channel that regul...
|
T79793 |
CRF1 receptor antagonist-1
|
2635364-30-4
|
98%
|
|
CRF1 Receptor Antagonist-1 (Compound 2), a CRF1 receptor antagonist, is utilized in research pertaining to congenital adrenal hyperplasia (CAH) [1].
|
T2355 |
CFTR(inh)-172
|
307510-92-5
|
99.94%
|
|
CFTR(inh)-172 (CFTR Inhibitor-172) is a voltage-independent, selective CFTR inhibitor.
|
T20341 |
DNDS
|
3709-43-1
|
99.88%
|
|
DNDS is a channel blocker of voltage-dependent cystic fibrosis transmembrane conductance regulator (CFTR).
|
T5312 |
CFTR corrector 2
|
1628416-28-3
|
99.88%
|
|
CFTR corrector 2 (FDL169) is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients w...
|
T16516 |
PG01
|
853138-65-5
|
99.87%
|
|
PG01 is a potent CFTR Cl-channel potentiator, effective against ΔF508 (Ka 0.3 μM), and also against E193K, G970R and G551D (CFTR mutants), with Kd values of 0.22...
|
T30293 |
Bamocaftor
|
2204245-48-5
|
99.85%
|
|
Bamocaftor is a CFTR channel (DeltaF508-CFTR mutation) corrector for CF transmembrane conductance regulators designed to restore F508del-CFTR protein function. C...
|
T7083 |
GLPG1837
|
1654725-02-6
|
99.73%
|
|
GLPG1837 (ABBV-974) is an effective CFTR potentiator, with EC50s of 3 nM and 339 nM for F508del and G551D CFTR, respectively.
|
T2595 |
Lumacaftor
|
936727-05-8
|
99.72%
|
|
Lumacaftor (VRT 826809) is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (...
|
T0429 |
Glucosamine
|
3416-24-8
|
99.72%
|
|
Glucosamine (Chitosamine) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Supplemental glucosamine ...
|
T3135 |
KM11060
|
774549-97-2
|
99.67%
|
|
KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma ...
|
T63806 |
CFTR corrector 8
|
1918142-35-4
|
99.58%
|
|
CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). This compound is specifically designed for ut...
|
T1805 |
Ataluren
|
775304-57-9
|
99.45%
|
|
Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Du...
|
T1634 |
Glibenclamide
|
10238-21-8
|
99.39%
|
|
Glibenclamide (Glyburide) is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.
|
T1874 |
PPQ-102
|
931706-15-9
|
99.17%
|
|
PPQ-102 (CFTR Inhibitor), an effective CFTR inhibitor, can completely inhibit CFTR chloride current (IC50: 90 nM).
|
T26955 |
Cavosonstat
|
1371587-51-7
|
98.91%
|
|
Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor that promotes cystic fibrosis transmembrane conductance regulator (CFTR...
|
T14935 |
Elexacaftor
|
2216712-66-0
|
98.87%
|
|
Elexacaftor (VX-445) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR) and it also facilitates the processing and trafficking of CFTR ...
|
T2263 |
Tezacaftor
|
1152311-62-0
|
98.84%
|
|
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
|
T77604 |
WAY-326766
|
853138-67-7
|
98.76%
|
|
WAY-326766 increases ion transport through mutant CFTR and can be used to alter the lifespan of eukaryotes.WAY-326766 can be used to treat cystic fibrosis (CF).
|